Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on […]
Cemtrex Issues Shareholder Letter and Provides Corporate Update
Brooklyn, NY, Feb. 28, 2024 (GLOBE NEWSWIRE) — – Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial […]
Gaxos Health Forms Medical Advisory Board to Support Launch of AI-powered Health and Wellness Solution
Roseland, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications […]
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
BEDFORD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to […]
Rent the Runway Names Natalie McGrath Chief Marketing Officer
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Rent the Runway (RTR) today announced the appointment of Natalie McGrath as […]
HeartCore Announces the Establishment of HeartCore Luvina Vietnam Co., Ltd.
NEW YORK and TOKYO, Feb. 28, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a […]
Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical […]
Nano Dimension Announces Important Business Updates:
The Company Plan for the Buy Back of Up to $200 Million of Shares Recently Commenced at Compelling Valuation Levels, […]
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024 […]
